DealsGoldman PE arm buys MyEyeDr in $2.7B deal, producing 3.5x return for Altas PartnersBySarah Pringle3 June 2019•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareFeatured